COVID-19 vaccination in the United States
BioNTech is Already Working on Vaccine for the Covid Variant Omicron
BioNTech has begun work on a vaccine specifically for the new variant of the coronavirus Omicron, which was first identified in South Africa.
The development of an adapted vaccine is part of the standard procedure.
The first steps for a possible new vaccine are carried out in parallel with the assessment of whether one will be needed after the advent of Omicron.
Will Vaccines Stop the Omicron Variant
Will the vaccines stop the Omicron variant of the coronavirus, the New York Times asks. The new version raises new concerns, because if it turns out that the existing vaccines do not affect it, they will have to be modified, the American publication notes.
- Read more about Will Vaccines Stop the Omicron Variant
- Log in to post comments
Britain to convene Meeting of G-7 Health Ministers over Omicron
Britain has announced that it will convene an emergency meeting of G-7 health ministers tomorrow to discuss developments in the new coronavirus variant, Omicron, Reuters reported.
Covid vaccine boosters recommended for all adults
Ljubljana – Slovenia’s national advisory committee on immunization has decided to recommend a booster shot of a vaccine against Covid-19 to all adults, that is everyone aged 18 or over.
- Read more about Covid vaccine boosters recommended for all adults
- Log in to post comments
Pfizer and Moderna expect Data on Vaccine Protection against New Covid Variant Soon
Biontech says it expects to have more data within two weeks to help determine whether the coronavirus vaccine, which it co-developed with Pfizer, needs to be reworked because of a new version of the coronavirus discovered in South Africa.
Pfizer and Biontech have said they expect to be able to deliver a possible new vaccine made for the new version in about 100 days, if necessary.
What is the Situation with COVID-19 in the Balkans
Over the past week, some Balkan countries have seen some improvement in epidemiological indicators, while others have tightened restrictive measures against unvaccinated people in an attempt to avoid a worsening of the situation ahead of the upcoming Christmas and New Year holidays.
- Read more about What is the Situation with COVID-19 in the Balkans
- Log in to post comments
WHO: COVID-19 Vaccines Saved Nearly 470,000 Lives of People over 60 in 33 European Countries
The COVID-19 vaccine has saved 469,186 lives for people aged 60 and over in 33 countries in the WHO European Region since the start of the vaccination campaign. This is evidenced by the results of a new study by the WHO Regional Office for Europe and the European Center for Disease Prevention and Control (ECDC), the organizations said in a press release, quoted by TASS.
Pfizer Vaccine is Now Recommended for Children aged 5 to 11
The Commission for Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EDA) has recommended that the use of the Comirnaty vaccine by Biontech / Pfizer against COVID-19 be given to children aged 5 to 11 years.
The vaccine is already used on children that are 12 years old.
Study: COVID Protection Weakens Gradually after Second Dose of the Pfizer Vaccine
A study published in the British Medical Journal found a gradual increase in the risk of COVID-19 on the 19th day after taking a second dose of the Pfizer / Biontech vaccine against the new coronavirus, Medical Express reported.
German Health Minister: "By Spring, Everyone will be Vaccinated, Recovered or Dead."
In the spring at the latest, everyone living in Germany will be immune to the disease. They will either be vaccinated, recovered, or dead. This was stated today at a press conference by the Minister of Health Jens Spahn.